← Eichor
Condition: Refractory Cancer Pain Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Refractory Cancer Pain

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025
Phase N/A · 1 location(s) · Bernardino Clavo, MD, PhD · NCT05417737Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
Phase 1 · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT00804154Psilocybin in Cancer Pain Study
Phase 2 · 1 location(s) · Yvan Beaussant, MD, MSci · NCT06001749Intrathecal Therapy Versus Standard Care for Severe Cancer Pain
NA · 1 location(s) · Universitair Ziekenhuis Brussel · NCT07691840The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.
EARLY_Phase 1 · 1 location(s) · National and Kapodistrian University of Athens · NCT07408193
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.